Analysis of FDA-Approved Anti-Cancer Agents in the NCI60 Panel of Human Tumor Cell Lines

Por Holbeck, Susan L., Collins, Jerry M., Doroshow, James H.
Publicado em 2010

Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo

Por Gaur, Arti B., Holbeck, Susan L., Colburn, Nancy H., Israel, Mark A.
Publicado em 2011

Biological evaluation of tubulysin A: a potential anticancer and antiangiogenic natural product

Por Kaur, Gurmeet, Hollingshead, Melinda, Holbeck, Susan, Schauer-Vukašinović, Vesna, Camalier, Richard F., Dömling, Alexander, Agarwal, Seema
Publicado em 2006

Expression Profiling of Nuclear Receptors in the NCI60 Cancer Cell Panel Reveals Receptor-Drug and Receptor-Gene Interactions

Por Holbeck, Susan, Chang, Jianjun, Best, Anne M., Bookout, Angie L., Mangelsdorf, David J., Martinez, Elisabeth D.
Publicado em 2010

Two CD95 tumor classes with different sensitivities to antitumor drugs

Por Algeciras-Schimnich, Alicia, Pietras, Eric M., Barnhart, Bryan C., Legembre, Patrick, Vijayan, Shrijay, Holbeck, Susan L., Peter, Marcus E.
Publicado em 2003

Antiproliferative Mechanisms of Action of the Flavin Dehydrogenase Inhibitors Diphenylene Iodonium and Di-2-thienyliodonium Based on Molecular Profiling of the NCI-60 Human Tumor C...

Por Doroshow, James H., Juhasz, Agnes, Ge, Yun, Holbeck, Susan, Lu, Jiamo, Antony, Smitha, Wu, Yongzhong, Jiang, Guojian, Roy, Krishnendu
Publicado em 2012

HLA class I and II genotype of the NCI-60 cell lines

Por Adams, Sharon, Robbins, Fu-Meei, Chen, Deborah, Wagage, Devika, Holbeck, Susan L, Morse, Herbert C, Stroncek, David, Marincola, Francesco M
Publicado em 2005

Identification of Compounds that Correlate with ABCG2 Transporter Function in the National Cancer Institute Anticancer Drug Screen

Por Deeken, John F., Robey, Robert W., Shukla, Suneet, Steadman, Kenneth, Chakraborty, Arup R., Poonkuzhali, Balasubramanian, Schuetz, Erin G., Holbeck, Susan, Ambudkar, Suresh V., Bates, Susan E.
Publicado em 2009

The National Cancer Institute ALMANAC(): A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic Activity

Por Holbeck, Susan L., Camalier, Richard, Crowell, James A., Govindharajulu, Jeevan Prasaad, Hollingshead, Melinda, Anderson, Lawrence W., Polley, Eric, Rubinstein, Larry, Srivastava, Apurva, Wilsker, Deborah, Collins, Jerry M., Doroshow, James H.
Publicado no Cancer Res (2017)

Phosphorylated fraction of H2AX as a measurement for DNA damage in cancer cells and potential applications of a novel assay

Por Ji, Jiuping, Zhang, Yiping, Redon, Christophe E., Reinhold, William C., Chen, Alice P., Fogli, Laura K., Holbeck, Susan L., Parchment, Ralph E., Hollingshead, Melinda, Tomaszewski, Joseph E., Dudon, Quentin, Pommier, Yves, Doroshow, James H., Bonner, William M.
Publicado no PLoS One (2017)

The Exomes of the NCI-60 Panel: a Genomic Resource for Cancer Biology and Systems Pharmacology

Por Abaan, Ogan D., Polley, Eric C., Davis, Sean R., Zhu, Yuelin J., Bilke, Sven, Walker, Robert L., Pineda, Marbin, Gindin, Yevgeniy, Jiang, Yuan, Reinhold, William C., Holbeck, Susan L., Simon, Richard M., Doroshow, James H., Pommier, Yves, Meltzer, Paul S.
Publicado no Cancer Res (2013)

Gene expression profiling of 49 human tumor xenografts from in vitro culture through multiple in vivo passages - strategies for data mining in support of therapeutic studies

Por Hollingshead, Melinda G, Stockwin, Luke H, Alcoser, Sergio Y, Newton, Dianne L, Orsburn, Benjamin C, Bonomi, Carrie A, Borgel, Suzanne D, Divelbiss, Raymond, Dougherty, Kelly M, Hager, Elizabeth J, Holbeck, Susan L, Kaur, Gurmeet, Kimmel, David J, Kunkel, Mark W, Millione, Angelena, Mullendore, Michael E, Stotler, Howard, Collins, Jerry
Publicado em 2014